{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T10:01:51Z","timestamp":1790330511120,"version":"4.1.0"},"reference-count":26,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T00:00:00Z","timestamp":1351641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The European Journal of Contraception &amp; Reproductive Health Care"],"published-print":{"date-parts":[[2012,12,1]]},"DOI":"10.3109\/13625187.2012.723225","type":"journal-article","created":{"date-parts":[[2012,10,31]],"date-time":"2012-10-31T15:23:07Z","timestamp":1351696987000},"page":"482-486","source":"Crossref","is-referenced-by-count":1,"title":["Preparing for PrEP"],"prefix":"10.1080","volume":"17","author":[{"given":"Patrick","family":"Lacor","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Infectious Diseases Unit, Universitair Ziekenhuis Brussel","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,10,31]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1011205"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1110711"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1202614"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1108524"},{"key":"e_1_3_2_6_1","unstructured":"Clinical trial of antiretroviral-based HIV prevention strategies for women now under way.NIH News. U.S. Department of Health and Human Services \u2013 National Institutes of Health 2009. Accessed 24 July 2012 from: \u201chttp:\/\/www.niaid.nih.gov\/news\/newsreleases\/2009\/Pages\/VOICE.aspx\u201d"},{"key":"e_1_3_2_7_1","unstructured":"MTN statement on decision to discontinue use of tenofovir gel in VOICE a major HIV prevention study in women.Microbicide Trials Network (MTN) 2011. Accessed 24 July 2012 from: http:\/\/www.mtnstopshiv.org\/node\/3909"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10865-006-9066-3"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.292.2.224"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1086\/651478"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1207438"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyh307"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1113643"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1105243"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/597095"},{"key":"e_1_3_2_16_1","first-page":"65","volume":"60","author":"Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men","year":"2011","unstructured":"Interim guidance: Preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR 2011;60:65\u20138.","journal-title":"MMWR"},{"key":"e_1_3_2_17_1","article-title":"advisory panel backs preventive use of H.I.V. drug","volume":"5","author":"Grady D. F.D.A","unstructured":"Grady D. F.D.A. advisory panel backs preventive use of H.I.V. drug. New York Times 10 May 2012:D5.","journal-title":"New York Times"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp068141"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/jme.2010.036525"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.10.1238"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.3.293"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007339720807"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.05.028928"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-139X(03)00301-X"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/ejcn.2009.145"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1368980011000383"},{"key":"e_1_3_2_27_1","unstructured":"Lancement de l'essai ANRS Ipergay. Le 1er essai de pr\u00e9vention pr\u00e9-exposition du VIH pour les gays en France. Agence nationale de recherches sur le sida et les h\u00e9patites virales (ANRS) 2012. Accessed 24 July 2012 from: http:\/\/www.anrs.fr\/VIH-SIDA\/Clinique\/Actualites"}],"container-title":["The European Journal of Contraception &amp; Reproductive Health Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/13625187.2012.723225","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.3109\/13625187.2012.723225","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/13625187.2012.723225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:18:47Z","timestamp":1790327927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/13625187.2012.723225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,31]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,12,1]]}},"alternative-id":["10.3109\/13625187.2012.723225"],"URL":"https:\/\/doi.org\/10.3109\/13625187.2012.723225","relation":{},"ISSN":["1362-5187","1473-0782"],"issn-type":[{"value":"1362-5187","type":"print"},{"value":"1473-0782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,31]]}}}